type 2 diabetes

Once-daily diabetes drug approvedFDA approved 10 mg dapagliflozin and 5 mg saxagliptin (Qtern, AstraZeneca), to treat type 2 diabetes.
Six diseases reap benefits of biomarkers, genetic tests
Six diseases reap benefits of biomarkers, genetic testsBiomarker testing for harmful genetic mutations provides the opportunity to identify at-risk individuals who might benefit from risk modification strategies and/or enhanced disease screening.
How obesity and related conditions are skyrocketingObesity is rising in children and teens, according to a new report, but other health problems tied to obesity are increasing, too.
Get smart about metabolic syndrome!As pediatricians we are all too aware of our nation’s struggle with childhood overweight and obesity. Approximately 1 of every 5 children that we see in the office every day is obese. Despite tremendous efforts to reverse this trend, it is clear we are in this battle for the long haul.
How to test kids for diabetesTesting glycated hemoglobin (HbA1c) appears to predict children’s diabetes risk as well as fasting plasma glucose and 2-hour postload plasma glucose, according to a study on more than 2000 American Indian children.
New device could be breakthrough for diabeticsFDA recently expanded approval of the G5 Mobile Continuous Glucose Monitoring System (Dexcom) to allow for replacement of fingerstick blood glucose (sugar) testing for diabetics.
New diabetes combo drug available soonA new combination drug for type 2 diabetes will available in the US in the coming months.
FDA approves lixisenatide for type 2 diabetesNew drug review
New drug indication could net more than $1 billionFDA’s approval of a new indication for empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) could net the pharmaceutical manufacturers more than $1 billion.
FDA approves 2 injectable diabetes drugsTwo new diabetes drugs, both long-acting injectable insulin products, were simultaneously approved by FDA.